Latest Capital Markets News

Pathkey.AI has secured a significant commercial contract with Imunexus Therapeutics, deploying its AI-driven TrialKey platform to enhance early-phase clinical trial design and capital raising efforts.

Empire Resources Limited has completed the issuance of 1 million shares under the second tranche of its placement, following shareholder approval at the recent extraordinary meeting. This move strengthens the company’s capital base as it pushes forward with its gold and copper projects in Western Australia.

Betashares Capital Ltd has announced the Distribution Reinvestment Plan (DRP) issue prices for 30 of its ETFs for the March 2026 distribution period, with elections due by 7 April and unit issuance scheduled for 20 April.

Dateline Resources has bolstered its financial position with a $50 million institutional placement, setting the stage for rapid development of its Colosseum Gold-REE Project in California. The company is on track to complete its Bankable Feasibility Study by April 2026, advancing towards production and project financing.

AVITA Medical has lodged a new $200 million shelf registration with the SEC, renewing its capacity to issue various securities in the US market. While no immediate capital raising is planned, this move preserves the company’s financial agility for future growth opportunities.

Patrys Limited is advancing a proprietary injectable formulation of quetiapine aimed at the large and underserved delirium treatment market, leveraging an accelerated FDA approval pathway and extensive existing safety data.

Galilee Energy has appointed a US Advisory Board to drive its Gulf Coast oil and gas expansion, targeting low-risk brownfield assets. The company’s maiden Zydeco-1 well in Louisiana is set to spud in Q2 2026, marking a key milestone in its US growth strategy.

KMD Brands has requested a voluntary suspension of its shares on both the NZX and ASX as it finalises a capital raise, refinancing, and its half-year financial results. The suspension aims to maintain market order while key details remain under negotiation.

iCandy Interactive has announced plans for Lemon Sky Studios to pursue a US IPO on the NYSE American, targeting a US$15 million capital raise, while highlighting strategic pivots in AI and blockchain markets.

Spacetalk Ltd has secured firm commitments to raise approximately $6 million through a two-tranche share placement, alongside appointing Andrew Grover as an independent Non-Executive Director. The capital raise aims to accelerate app development and support growing subscriber demand.

Syrah Resources has successfully closed its institutional entitlement offer, securing A$44 million at a share price of 10.5 cents, with the retail offer now open to shareholders. This capital raise aims to strengthen the company’s financial position as it advances its graphite and anode material operations.

4DMedical has achieved CE Mark certification for its groundbreaking CT:VQ™ ventilation-perfusion imaging technology, unlocking the vast European market. The company also raised $83 million to fund rapid expansion across the EU.